NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or “the Company”) (NASDAQ: TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced that its wholly-owned subsidiary Tilray Portugal Unipessoal... read more →
After a brutal finish to 2018, Marijuana stocks started off 2019 absolutely on fire. The majority of Cannabis stocks have completely smoked the market and left investors sitting with substantial gains. Most... read more →
If you have any experience in Technical Analysis, take one glance at a 1-year candlestick chart of Tilray Inc. (NASDAQ: TLRY) and one aspect of their chart should immediately be apparent... read more →
Canopy Growth Adds Martha Stewart as Advisor, Will Assist on New Hemp CBD Products: Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and Sequential Brands Group, Inc. (NASDAQ: SQBG) announced today that Martha Stewart... read more →
Martha Stewart to join as advisor on hemp-derived CBD products SMITHS FALLS, ON and NEW YORK, Feb. 28, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NYSE: CGC) and Sequential... read more →
Epidiolex® (cannabidiol) oral solution (CV), first FDA-approved plant-derived cannabinoid medicine, launched in the U.S. in November to high awareness and demand GW moves to a new fiscal year-end beginning January 1,... read more →
TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announced that at a Special Meeting held today, the Company’s shareholders... read more →
Canopy Growth Reports Record Q3 Net Revenue of $83 Million: Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“Canopy Growth” or “the Company”) today released its consolidated financial results for the third quarter... read more →
Acquisition unites cannabis pioneer with leading natural food CPG company to create hemp and CBD-infused food and wellness products for North America NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or “the... read more →
Aleafia Health Patient Outcomes Point to Potential Pivot from Opioids and Benzos towards Medical Cannabis—a potential $25 Billion shift Heading into the last week of January, vertically integrated Canadian medicinal... read more →